TY  - JOUR
PY  - 2019//
TI  - E-cigarette product use, or vaping, among persons with associated lung injury - Illinois and Wisconsin, April-September 2019
JO  - MMWR: Morbidity and mortality weekly report
A1  - Ghinai, Isaac
A1  - Pray, Ian W.
A1  - Navon, Livia
A1  - O'Laughlin, Kevin
A1  - Saathoff-Huber, Lori
A1  - Hoots, Brooke E.
A1  - Kimball, Anne
A1  - Tenforde, Mark W.
A1  - Chevinsky, Jennifer R.
A1  - Layer, Mark
A1  - Ezike, Ngozi
A1  - Meiman, Jonathan
A1  - Layden, Jennifer E.
SP  - 865
EP  - 869
VL  - 68
IS  - 39
N2  - In July 2019, the Illinois Department of Public Health and the Wisconsin Department of Health Services launched a coordinated epidemiologic investigation after receiving reports of several cases of lung injury in previously healthy persons who reported electronic cigarette (e-cigarette) use, or vaping (1). This report describes features of e-cigarette product use by patients in Illinois and Wisconsin. Detailed patient interviews were conducted by telephone, in person, or via the Internet with 86 (68%) of 127 patients. Overall, 75 (87%) of 86 interviewed patients reported using e-cigarette products containing tetrahydrocannabinol (THC), and 61 (71%) reported using nicotine-containing products. Numerous products and brand names were identified by patients. Nearly all (96%) THC-containing products reported were packaged, prefilled cartridges, and 89% were primarily acquired from informal sources (e.g., friends, family members, illicit dealers, or off the street). In contrast, 77% of nicotine-containing products were sold as prefilled cartridges, and 83% were obtained from commercial vendors. The precise source of this outbreak is currently unknown (2); however, the predominant use of prefilled THC-containing cartridges among patients with lung injury associated with e-cigarette use suggests that they play an important role. While this investigation is ongoing, CDC recommends that persons consider refraining from using e-cigarette, or vaping, products, particularly those containing THC. Given the diversity of products reported and frequency of patients using both THC- and nicotine-containing e-cigarette products, additional methods such as product testing and traceback could help identify the specific cause of this outbreak.<p />  <p>Language: en</p>
LA  - en
SN  - 0149-2195
UR  - http://dx.doi.org/10.15585/mmwr.mm6839e2
ID  - ref1
ER  -